STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Schedule of PIPE Purchase Agreements

On November 15, 2024, we entered into a Securities Purchase Agreement (the “Alta PIPE Purchase Agreement”) with Alta Fundamental Advisers Master LP (“Alta Fundamental”), Star V Partners LLC (“Star V”) and Blackwell Partners LLC – Series A (“Blackwell” together with Alta Fundamental and Star V, the “Alta PIPE Purchasers”), each an advisory client of Alta Fundamental Advisers, LLC, for the sale and issuance of common stock as follows:

Purchaser	Number of Shares	Price per Share		Proceeds
Alta Fundamental	3,474,757	$	1.03	$	3,579,000
Star V	2,363,592	1.03		2,434,500
Blackwell	8,724,757	1.03		8,986,500
	14,563,106	$	1.03	$	15,000,000

We also entered into a Securities Purchase Agreement (the “CCM PIPE Purchase Agreement” and together with the Alta PIPE Purchase Agreement, the “PIPE Purchase Agreements”) with Coliseum Capital Partners, L.P. (“CCP”) and Blackwell (Blackwell together with CCP, the “CCM PIPE Purchasers” and together with the Alta PIPE Purchasers, the “PIPE Investors”), each an advisory client of Coliseum Capital Management, LLC, as follows for the sale and issuance of common stock:

Purchaser	Number of Shares	Price per Share		Proceeds
CCP	10,922,330	$	1.03	$	11,250,000
Blackwell	3,640,776	1.03		3,750,000
	14,563,106	$	1.03	$	15,000,000

Schedule of ESPP Activity

ESPP activity was as follows:

	Year Ended December 31, 2024
Shares purchased pursuant to the ESPP	37,295
Weighted average per share price of shares purchased	$	3.03
Weighted average per share discount from market value for shares purchased	$	0.45
Stock-based compensation related to ESPP	$	64,613

Schedule of Warrants Activity

In connection with the Advance on our Coliseum Loan as discussed in Note 15 - Debt, we issued warrants to clients of Coliseum Capital Management as follows:

	Shares Underlying Warrants	Weighted Average Exercise Price
Warrants outstanding December 31, 2023	—	$	—
Granted	2,000,000	5.25
Converted	8,194,174
Warrants outstanding December 31, 2024	10,194,174	$	3.83

Schedule of Stock Option Activity

Stock option activity was as follows:

	Shares Underlying Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2023	376,940	$	11.21	1.91	$	—
Granted	1,500,000	2.00
Cancelled or terminated	(144,172)	8.94
Outstanding at December 31, 2024	1,732,768	3.43		9.25	—
Outstanding and vested at December 31, 2024	203,626	12.64		5.98	—

Schedule of Restricted Stock Unit Activity

Restricted stock unit (“RSU”) activity was as follows:

	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2023	238,275	$	13.35
Granted	316,256	3.33
Vested	(115,324)	11.85
Forfeited	(214,445)	9.41
Outstanding at December 31, 2024	224,762	$	3.78

Schedule of Stock-based Compensation

Stock-based compensation was as follows:

	Year Ended December 31,
(In thousands)	2024		2023
ESPP	$	65	$	180
2018 Plan	1,686		2,069
	$	1,751	$	2,249

Certain other information regarding stock-based compensation was as follows:

	Year Ended December 31,
	2024		2023
Per share weighted average grant date fair value of awards issued	$	3.33	$	12.14
Intrinsic value of stock options exercised (in thousands)	—		617.9
Current tax benefit related to stock-based awards (in thousands)	4.5		3.3

Schedule of Fair Value of Options Valuation Assumptions

The fair value of options was based on the following assumptions:

	Year Ended December 31, 2024
	ESPP		2018 Plan
Risk free interest rate	5.33%-5.43%		4	%
Expected term (years)	0.42-0.58		6
Expected volatility	52%-93%		70	%
Expected dividends	0.00	%	0.00	%